In a study by Korff et al., CSF α-synuclein levels were significantly higher in individuals with mild cognitive impairments and Alzheimer’s disease patients compared to controls [379] (Table 3). This evidence concerns the gene SNCA and early-onset autosomal dominant Alzheimer disease.